Why is Mono Pharmacare falling/rising?

As of 03-Sep, Mono Pharmacare Ltd is currently priced at 22.50, with no change in its stock price, reflecting a percentage change of 0.00%. The stock has underperformed its sector by 1.24% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, the delivery volume has decreased by 9.09% compared to the 5-day average, suggesting a decline in investor participation. Over the past month, the stock has experienced a significant decline of 10.00%, and year-to-date, it has fallen by 35.06%. Unfortunately, there are no positive or negative factors available to provide further insights into the stock's recent movement.
In the broader market context, the stock's short-term performance over the past week shows a change of 0.00%, while the benchmark Sensex has increased by 0.01%. This indicates that Mono Pharmacare is not keeping pace with the market, which may contribute to investor concerns. Over the past month, while the stock has decreased by 10.00%, the Sensex has gained 0.61%, further highlighting the underperformance of Mono Pharmacare relative to the broader market. The year-to-date decline of 35.06% for the stock starkly contrasts with the Sensex's positive return of 4.53%, emphasizing the challenges faced by Mono Pharmacare in the current market environment.